CMS Releases CY 2027 Advance Notice: Key Considerations for Medicare Advantage Plans

January 30, 2026

CMS has released its CY 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. While the proposed updates reflect relative payment stability, they continue to reinforce CMS’s broader priorities around payment accuracy, data integrity, and quality measurement modernization.


Key Takeaways


If finalized, the proposed policies are projected to result in a net average year-over-year payment increase of 0.09%, representing more than $700 million in additional MA payments for CY 2027.


Beyond the topline payment impact, CMS’s proposals signal continued focus in several important areas:


  • Greater payment accuracy and cost alignment, reinforcing CMS’s efforts to better match payments with beneficiary health status and underlying costs
  • Ongoing updates to risk adjustment methodology, aimed at reducing administrative burden while refining model accuracy
  • Star Ratings administrative updates, particularly affecting HEDIS-based measures transitioning to Electronic Clinical Data Systems (ECDS)-only reporting


Star Ratings: Quality Bonus Payment (QBP) Add-On


CMS proposes maintaining the current Quality Bonus Payment (QBP) structure applied to county benchmark rates:


STARS Quality Bonus Payment Percentage add-on to county rates*

Star Rating QBP Percentage
Fewer than 4 stars 0%
4.5, and 5 stars 5%

New MA plans and low-enrollment plans would continue to receive a 3.5% QBP.


How Advent Advisory Supports Plans


As CMS continues to modernize quality measurement and reporting expectations, Advent Advisory is working closely with health plans to navigate these changes.


For existing Medicare Advantage plans, we support:

  • Aligning data sources and reporting workflows to fully enable ECDS-based HEDIS reporting
  • Strengthening data governance and validation processes to support quality performance under evolving requirements


For organizations new to Medicare Advantage, we help:

  • Interpret reporting and submission requirements
  • Identify and assess eligible data sources that can support HEDIS ECDS reporting from the outset
  • Establish scalable reporting frameworks aligned with CMS expectations
CMS Releases CY 2027 Advance Notice: Key Considerations for Medicare Advantage Plans

Looking Ahead


While the CY 2027 Advance Notice reflects modest payment growth, it underscores CMS’s continued emphasis on data-driven accuracy, quality modernization, and operational readiness. Plans that invest early in aligning data, reporting, and quality infrastructure will be better positioned as these proposed policies move toward finalization.


Advent Advisory remains committed to helping health plans translate regulatory change into practical, sustainable execution.

Follow us on LinkedIn

Advent Advisory Group Insights

Operational Realities and Considerations for HEDIS MY 2027
March 18, 2026
Regulatory momentum is building around person-centered outcomes. NCQA’s proposed Person-Centered Outcome (PCO) measures for HEDIS MY 2027 aim to improve the quality of care for Special Needs Plans (SNPs), but operational realities make implementation challenging for many health plans.
HEDIS® 2026 Public Comment Period: Key Takeaways and Impact Analysis
February 19, 2026
NCQA has opened the 2026 HEDIS® Public Comment period, running from February 13 through March 13, 2026.
November 25, 2025
The CMS 2026 Program Audit Annual Updates bring several important changes that healthcare sponsors must address to stay compliant. These updates affect various aspects of the audit process, from condition classifications to new requirements for validation audits.
November 13, 2025
Aside from the usual updates to the audit timeline and other wording changes, this year’s HEDIS audit manual includes several changes of significance.
October 21, 2025
The Advent team had the opportunity to attend the NCQA Health Innovation Summit, where healthcare leaders and innovators came together to explore the next phase of digital quality measurement and value-based care.
October 16, 2025
HEDIS is shifting. Stars are flattening. Advantage goes to plans that act now. After several consecutive years of declines, the average Medicare Advantage (MA) Star Ratings are essentially flat for 2026.
October 10, 2025
As California leaders assess the sweeping implications of these proposed changes, Advent Advisory Group is helping health plans evaluate exposure, model financial impacts, and prepare operational strategies across Medicare, Medi-Cal, and Commercial lines.
Turning NCQA 2025 Health Plan Ratings into a Roadmap for Improvement
September 19, 2025
The 2025 NCQA Health Plan Ratings are out. For health plans, these results are more than just numbers — they’re a public reflection of quality, experience, and performance.
Tips for a Better CMS Program Audit Experience
August 26, 2025
CMS recently published its annual Part C and Part D Program Audit and Enforcement Report. The report provided recommendations and guidance for Sponsors to consider when preparing for future CMS Program Audits.
August 7, 2025
Advent’s HEDIS 2026 webinar series kicked off last month with Optimizing Clinical Data Quality, a presentation focused on common challenges with supplemental clinical data. Key takeaways include the following:  Transition in Data Collection: The shift from manual data collection to digital HEDIS reporting has increased the focus on clinical data over claims data. NCQA’s planned elimination of the hybrid reporting method has added urgency to this transition, driving plans to acquire more electronic clinical data and adapt to year-round ingestion. Challenges with Clinical Data: The presentation highlighted several challenges to the acquisition of supplemental clinical data, including data timing, completeness, and accuracy. Issues such as short turnaround times, missing biometric values, and incorrect coding have impacted the useability of these additional data sources for HEDIS reporting. Tips for Navigating the Transition: Plans can navigate this transition by starting early with clinical data validation, engaging with IT departments, exploring vendor’s reports and supportive capabilities, and building executive leadership buy-in.
More Posts